Cytoreductive surgery in patients with advanced ovarian cancer: Surgical complexity score and postoperative complications

Author:

Yakovleva M. G.1ORCID,Gorodnova T. V.1ORCID,Kotiv Kh. B.1ORCID,Smirnova O. A.1,Lavrinovich O. E.1ORCID,Mikaya N. A.1ORCID,Trifanov Yu. N.1,Guseynov K. D.1ORCID,Bakhidze E. V.2ORCID,Meshkova I. E.1,Nekrasova E. А.1,Shagal М. А.1,Тyatkov S. А.1,Okonechnikova D. V.1ORCID,Ulrich E. A.3ORCID,Urmancheeva A. F.2ORCID,Rostovcev D. M.4,Berlev I. V.2ORCID

Affiliation:

1. National Medical Research Centre of Oncology n. a. N. N. Petrov

2. National Medical Research Centre of Oncology n. a. N. N. Petrov; North-Western State Medical University n. a. I. I. Mechnikov

3. National Medical Research Centre of Oncology n. a. N. N. Petrov; North-Western State Medical University n. a. I. I. Mechnikov; National Medical Research Centre n. a. V. A. Almazov

4. Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine

Abstract

Introduction. Cytoreductive surgery in patients with advanced ovarian cancer often involves extensive combined surgical interventions, which can affect the development of postoperative complications.Aim. To evaluate the results of surgical treatment in patients with advanced ovarian cancer.Methods. The study included 190 primary IIB–IV stage ovarian cancer patients who underwent surgical treatment in the oncogynecological department of the National Medical Research Centre of Oncology n. a. N. N. Petrov (Saint Petersburg, Russia) from August 2017 to August 2020. The dissemination in the peritoneum was assessed by calculating the peritoneal carcinomatosis index (PCI). Surgical complexity score was assessed using Aletti’s classification. Analysis of postoperative complications was carried out in accordance with the Clavien – Dindo classification.Results. The incidence of postoperative complications depended on the index of surgical complexity score (5 % – with a low index, 15 % – with median, 63 % – with a high one, p < 0.0010). In the group of primary cytoreductive surgeries, cases of median (48.9 %) and high complexity score (24.44 %) prevailed; in the group of interval debulking surgery, cases of low (52.4 %) and median (36.5 %) complexity score prevailed. The index of surgical complexity score depended on the peritoneal carcinomatosis index (PCI). The operation time, the volume of blood loss, the duration of hospitalization, frequency of bowel resection depended on the peritoneal carcinomatosis index and the surgical complexity score (p < 0.0001).Conclusions. The level of surgical complexity score in patients with advanced ovarian cancer depends on the peritoneal carcinomatosis index. The level of surgical complexity score is higher in the group of primary debulking surgery, which effect on frequency of postoperative complications.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference17 articles.

1. Kotsopoulos J, Rosen B, Fan I, Moody J, McLaughlin JR, Risch H, May T, Sun P, Narod SA. Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status. Gynecol Oncol. 2016 Jan; 140 (1): 42–7. DOI: 10.1016/j.ygyno.2015.11.009. Epub 2015 Nov 7. PMID: 26556769.

2. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol. 2002 Mar 1; 20 (5): 1248–59. DOI: 10.1200/jco.2002.20.5.1248. PMID: 11870167.

3. du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer. 2009 Mar 15; 115 (6): 1234–44. DOI: 10.1002/cncr.24149. PMID: 19189349.

4. Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 1975 Oct; 42: 101–4. PMID: 1234624.

5. Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010 Sep 2; 363 (10): 943–53. DOI: 10.1056/nejmoa0908806. PMID: 20818904.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3